On 23 March 2021, the European Medicines Agency (EMA) confirmed that Alzheimer Europe continues to comply with its strict eligibility criteria, as defined by its Management Board, and can continue to be involved in its activities. The list of all the patients' and consumers' organisations that are involved in EMA activities can be viewed here:
